- Home
- NVAX vs CEPU Comparison
NVAX vs CEPU Comparison
Compare NVAX & CEPU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVAX
- CEPU
- Stock Information
- Founded
- NVAX 1987
- CEPU 1989
- Country
- NVAX United States
- CEPU Argentina
- Employees
- NVAX N/A
- CEPU N/A
- Industry
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- CEPU Electric Utilities: Central
- Sector
- NVAX Health Care
- CEPU Utilities
- Exchange
- NVAX Nasdaq
- CEPU Nasdaq
- Market Cap
- NVAX 1.3B
- CEPU 1.6B
- IPO Year
- NVAX 1995
- CEPU 2018
- Fundamental
- Price
- NVAX $7.34
- CEPU $13.03
- Analyst Decision
- NVAX Buy
- CEPU Hold
- Analyst Count
- NVAX 5
- CEPU 1
- Target Price
- NVAX $19.00
- CEPU $12.00
- AVG Volume (30 Days)
- NVAX 14.2M
- CEPU 366.8K
- Earning Date
- NVAX 05-08-2025
- CEPU 05-12-2025
- Dividend Yield
- NVAX N/A
- CEPU 2.38%
- EPS Growth
- NVAX N/A
- CEPU N/A
- EPS
- NVAX 2.97
- CEPU 0.06
- Revenue
- NVAX $1,254,962,000.00
- CEPU $697,204,690.00
- Revenue This Year
- NVAX $40.01
- CEPU $26.57
- Revenue Next Year
- NVAX N/A
- CEPU N/A
- P/E Ratio
- NVAX $2.47
- CEPU $22.04
- Revenue Growth
- NVAX 25.92
- CEPU N/A
- 52 Week Low
- NVAX $5.01
- CEPU $7.07
- 52 Week High
- NVAX $23.86
- CEPU $16.60
- Technical
- Relative Strength Index (RSI)
- NVAX 55.86
- CEPU 56.54
- Support Level
- NVAX $6.84
- CEPU $13.07
- Resistance Level
- NVAX $7.62
- CEPU $13.65
- Average True Range (ATR)
- NVAX 0.55
- CEPU 0.69
- MACD
- NVAX 0.07
- CEPU 0.02
- Stochastic Oscillator
- NVAX 50.52
- CEPU 52.99
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.
About CEPU Central Puerto S.A. (each represents ten)
Central Puerto SA is a private-sector power generation company. It is mainly engaged in electric power generation and commercialization. The company is also involved in the natural gas distribution public sector service in the Cuyo and Centro regions in Argentina. The Group has four reporting segments which includes electric power generation from conventional sources, electric power generation from renewable sources, natural gas transport and distribution, and forest activity.. The company derives maximum revenue from Electric Power Generation from conventional sources segment.